{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:31:54Z","timestamp":1790289114376,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,15]]},"DOI":"10.1093\/cid\/ciw829","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T13:27:11Z","timestamp":1485782831000},"page":"S30-S35","source":"Crossref","is-referenced-by-count":105,"title":["Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group"],"prefix":"10.1093","volume":"64","author":[{"given":"Yohei","family":"Doi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith S.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius J.","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua T.","family":"Thaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E.","family":"Stryjewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"van Duin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,2]]},"reference":[{"key":"key\n\t\t\t\t20170315152046_CIT0001","author":"World Health Organization","year":"2014"},{"key":"key\n\t\t\t\t20170315152046_CIT0002","author":"Review on Antimicrobial Resistance"},{"key":"key\n\t\t\t\t20170315152046_CIT0003","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.diagmicrobio.2014.07.005","article-title":"Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011)","volume":"80","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170315152046_CIT0004","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/cid\/cir202","article-title":"Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention","volume":"53","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170315152046_CIT0005","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/AAC.02636-14","article-title":"Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170315152046_CIT0006","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cmi.2016.01.023","article-title":"Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections","volume":"22","author":"Antibacterial Resistance Leadership Group","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170315152046_CIT0007","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/ice.2015.298","article-title":"Hospital readmissions in patients with carbapenem-resistant Klebsiella pneumoniae","volume":"37","author":"Antibacterial Resistance Leadership Group","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20170315152046_CIT0008","doi-asserted-by":"crossref","first-page":"O1117","DOI":"10.1111\/1469-0691.12714","article-title":"Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance","volume":"20","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170315152046_CIT0009","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1017\/ice.2015.118","article-title":"Residence in skilled nursing facilities is associated with tigecycline nonsusceptibility in carbapenem-resistant Klebsiella pneumoniae","volume":"36","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20170315152046_CIT0010","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/jac\/dku495","article-title":"Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170315152046_CIT0011","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1128\/AAC.00125-14","article-title":"Population structure of KPC-producing Klebsiella pneumoniae isolates from midwestern U.S. hospitals","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170315152046_CIT0012","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/cid\/civ003","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum \u03b2-lactamase bacteremia","volume":"60","author":"Antibacterial Resistance Leadership Group","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170315152046_CIT0013","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/cid\/ciw425","article-title":"A clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum \u03b2-lactamase-producing organism","volume":"63","author":"Antibacterial Resistance Leadership Group","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170315152046_CIT0014","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/cid\/civ837","article-title":"Rapid molecular diagnostics, antibiotic treatment decisions, and developing approaches to inform empiric therapy: PRIMERS I and II","volume":"62","author":"Antibacterial Resistance Leadership Group","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170315152046_CIT0015","article-title":"Informing antibiotic treatment decisions: evaluating rapid molecular diagnostics (RMDs) to identify susceptibility and resistance to carbapenems against Acinetobacter spp. PRIMERS III","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170315152046_CIT0016","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1128\/AAC.00107-16","article-title":"Global dissemination of blaKPC into bacterial species beyond Klebsiella pneumoniae and in vitro susceptibility to ceftazidime-avibactam and aztreonam-avibactam","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170315152046_CIT0017","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.diagmicrobio.2010.10.013","article-title":"Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections","volume":"69","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170315152046_CIT0018","first-page":"S13","article-title":"Leading antibacterial laboratory research by integrating conventional and innovative approaches: the Laboratory Center of the Antibacterial Resistance Leadership Group","volume":"64(Suppl 1)","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170315152046_CIT0019","first-page":"S18","article-title":"Fundamentals and catalytic innovation: the Statistical and Data Management Center of the Antibacterial Resistance Leadership Group","volume":"64(Suppl 1)","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170315152046_CIT0020","first-page":"S8","article-title":"Transforming concepts into clinical trials and creating a multisite network: the Leadership and Operations Center of the Antibacterial Resistance Leadership Group","volume":"64(Suppl 1)","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170315152046_CIT0021","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/ajt.12424","article-title":"Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20170315152046_CIT0022","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170315152046_CIT0023","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jiac.2016.01.010","article-title":"Fosfomycin: resurgence of an old companion","volume":"22","year":"2016","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20170315152046_CIT0024","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-0034-1398388","article-title":"Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options","volume":"36","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170315152046_CIT0025","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/jac\/dkq278","article-title":"Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City","volume":"65","year":"2010","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/64\/suppl_1\/S30\/10843314\/ciw829.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T21:39:56Z","timestamp":1749937196000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/3059920\/Gram-Negative"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,2]]},"references-count":25,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2017,3,2]]},"published-print":{"date-parts":[[2017,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciw829","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,2]]}}}